Tesamorelin: Handling, Storage, and Reconstitution Guide

Tesamorelin is a synthetic research peptide, 44 amino acids long, supplied as a lyophilized, or freeze-dried, powder. How well it performs in receptor and release assays depends on careful lab handling. This guide covers Tesamorelin storage, reconstitution, aliquoting, and records. All of it is lab best practice for in-vitro and animal-model preparation only. It is not human-use guidance.

How should Tesamorelin be stored?

Tesamorelin storage starts with the freeze-dried powder. For short-term handling, keep it sealed at or below 25 degrees Celsius, away from heat, light, and moisture. For long storage, keep the powder refrigerated or frozen. Cold, dry, dark conditions slow the chemical breakdown that affects peptides.

The trans-3-hexenoyl group helps the peptide resist cutting by enzymes. But that stability applies to the intact peptide in a biological system. It does not replace good storage. The dry powder is still far more stable than any solution. So labs keep the powder under validated conditions. They also keep storage records. These support the repeatable results discussed in our Tesamorelin research applications overview.

How is Tesamorelin reconstituted with bacteriostatic water?

For in-vitro work, Tesamorelin is usually reconstituted with bacteriostatic water. Add the water slowly down the inside wall of the vial, not right onto the powder. Swirl the vial gently until the peptide dissolves. Avoid vortexing and hard shaking, because physical stress can damage the peptide.

A reconstituted peptide is less stable than the dry powder. So handle solutions promptly and keep them cold. These choices directly affect the GHRH receptor and cAMP results in the Tesamorelin mechanism of action overview.

One point is worth repeating. Tesamorelin's resistance to enzymes does not mean it lasts forever in water. The trans-3-hexenoyl group guards against one specific enzyme in biological systems. But in water, the peptide still faces the normal breakdown that affects any peptide. Water can split it, and oxygen can damage it. So cold, prompt handling remains the rule.

• Reconstitute with bacteriostatic water for in-vitro prep.
• Add solvent slowly along the vial wall.
• Swirl gently, and do not vortex.
• Keep the solution cold and use it promptly.

Why aliquot Tesamorelin after reconstitution?

Repeated freezing and thawing is a common cause of peptide breakdown. So aliquoting is the standard protective step. After reconstitution, split the solution into single-use portions sized to the study design. Then each experiment draws from a fresh aliquot. No single stock gets thawed again and again.

Label aliquots with the lot number, concentration, and date. Store them under validated conditions. This protects peptide quality and creates a clear chain of custody. Labs apply the same habits to the short GHRH fragment often studied with Tesamorelin. The Sermorelin handling guide covers it.

How should concentration be planned for 10 mg and 20 mg vials?

Choose a working concentration that suits the assay and keeps the peptide fully dissolved. Tesamorelin comes in larger 10 mg and 20 mg vials. So plan the reconstitution volume to give a practical stock concentration. Confirm that the solution is clear and free of particles before use. Record the volume added against the labeled vial mass. Then the stock concentration can be calculated precisely.

Larger vials make aliquoting even more valuable. One reconstituted vial may supply many experiments. Splitting the stock promptly protects the whole amount. Otherwise, freeze-thaw cycles and warm exposure would build up with repeated use.

Plan the aliquot size around the study's usual experiment. This cuts both waste and handling stress. Say each aliquot matches one day's work. Then the rest of the material stays frozen and untouched. That is the most reliable way to preserve activity over the long timelines that larger vials tend to support.

What does the Tesamorelin certificate of analysis show?

Each Tesamorelin batch ships with a certificate of analysis, or CoA, checked by a third party. It documents:

• Purity, by HPLC or reverse-phase chromatography
• Identity, confirmed by mass spectrometry
• Lot number, test date, and method details

This gives labs clear, research-grade quality control.

The mass spectrometry data is a useful identity check. It confirms the material matches the expected molecular weight of about 5136 g/mol for the stable GHRH(1-44) sequence. On receipt, teams check the certificate against the vial label. They record the lot number in inventory. They file the CoA so it is ready for audits. Sample CoAs can be requested before purchase.

How should labs document and trace Tesamorelin batches?

Beyond the certificate, labs log handling steps, storage conditions, and reconstitution details. Then every result can be traced back to one batch. The same standards apply to combined GHRH and ghrelin products, such as those in the Tesamorelin plus Ipamorelin blend handling guide. This tracing is what lets data from different studies be compared with confidence.

Tesamorelin is supplied as a 10 mg or 20 mg lyophilized research vial for lab use. The practical base for repeatable GHRH analog data is simple. Protect material quality from cold-chain receipt, through careful reconstitution, to aliquoting.

For research use only. Not for human or veterinary use. All statements describe reported findings in preclinical and in-vitro research models and are provided for laboratory reference only.